Please use this identifier to cite or link to this item:
|Title:||A dimerized coiled-coil domain and an adjoining part of geminin interact with two sites on Cdt1 for replication inhibition||Authors:||Saxena, S.
|Issue Date:||23-Jul-2004||Citation:||Saxena, S., Yuan, P., Dhar, S.K., Senga, T., Takeda, D., Robinson, H., Kornbluth, S., Swaminathan, K., Dutta, A. (2004-07-23). A dimerized coiled-coil domain and an adjoining part of geminin interact with two sites on Cdt1 for replication inhibition. Molecular Cell 15 (2) : 245-258. ScholarBank@NUS Repository. https://doi.org/10.1016/j.molcel.2004.06.045||Abstract:||Geminin is a cellular protein that associates with Cdt1 and inhibits Mcm2-7 loading during S phase. It prevents multiple cycles of replication per cell cycle and prevents episome replication. It also directly inhibits the HoxA11 transcription factor. Here we report that geminin forms a parallel coiled-coil homodimer with atypical residues in the dimer interface. Point mutations that disrupt the dimerization abolish interaction with Cdt1 and inhibition of replication. An array of glutamic acid residues on the coiled-coil domain surface interacts with positive charges in the middle of Cdt1. An adjoining region interacts independently with the N-terminal 100 residues of Cdt1. Both interactions are essential for replication inhibition. The negative residues on the coiled-coil domain and a different part of geminin are also required for interaction with HoxA11. Therefore a rigid cylinder with negative surface charges is a critical component of a bipartite interaction interface between geminin and its cellular targets.||Source Title:||Molecular Cell||URI:||http://scholarbank.nus.edu.sg/handle/10635/99824||ISSN:||10972765||DOI:||10.1016/j.molcel.2004.06.045|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Oct 13, 2019
WEB OF SCIENCETM
checked on Oct 4, 2019
checked on Oct 12, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.